Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
- Status
- RECRUITING
- Phase
- N/A
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
- Status
- COMPLETED
- Phase
- NA
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
- Status
- RECRUITING
- Phase
- N/A
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- Status
- RECRUITING
- Phase
- N/A
Study to Examine Lesions of the Skin Using Confocal Laser Microscopy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Status
- RECRUITING
- Phase
- PHASE2
Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Personalised Immunotherapy Platform
- Status
- RECRUITING
- Phase
- N/A
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2